Some patients with dry Age-Related Macular Degeneration (ARMD) have vision improvements after taking high doses a statin. The common cholesterol-lowering drug is called Atorvastatin. It is the statin drug used in a phase I/II clinical trial at Massachusetts Eye and Ear at Harvard Medical School and the University of Crete. A higher-than-normal dose of the drug caused lipid deposits behind the retina to dissolve in some patients.
Statin drugs are FDA approved for controlling blood Continue reading “Dry Macular Degeneration May Improve with High-Dose Statin Cholesterol Drug”

Retinal Vein Occlusion is the blockage of veins that drain blood from the retina in the eye. The eye circulatory system depends on releasing blood back to the heart after it has nourished the retina. When the vein is blocked, hemorrhaging occurs, damaging the retina. It is typically caused by atherosclerosis, a common condition especially in older people that damages the arteries. “Occlusion” means the blockage or closing of a blood vessel.
A recent study linking cholesterol and macular degeneration may shed light on a highly significant problem caused by aging and potentially illuminates hope for a treatment or perhaps even a cure.
Patients taking statin drugs to lower cholesterol might be more likely to get muscle injuries, especially elderly patients.(1) Side effects and adverse reactions, according to other research, may include increased stroke risk, higher risk of Type II Diabetes, low iron, pancreatic dysfunction, sexual dysfunction, suppressed immune system, muscle pain, and more.